Skip to main content
QTTB logo

QTTB

Q32 Bio Inc

$15.70

14.95%

Trade Ideas Performance

Latest Closed Trade Idea

$15.70

14.95%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

13

Social

11

About

Events of Q32 Bio Inc (QTTB)

In May 2026, Q32 Bio reported its First Quarter 2026 financial results, provided a corporate update, reiterated a "Buy" rating by HC Wainwright, and issued a warning regarding regulatory compliance risks. In April 2026, Q32 Bio expanded its at-the-market offering and participated in the 25th Annual Needham Virtual Healthcare Conference. In March 2026, Q32 Bio reported its Fourth Quarter 2025 financial results, completed enrollment in Part B of the SIGNAL-AA Phase 2a clinical trial, completed a $10.5 million registered direct offering, and sold ADX-097 to Akebia Therapeutics. In February 2026, Q32 Bio completed a $10.5 million registered direct offering of common stock and pre-funded warrants. In December 2025, the company completed the asset sale of ADX-097 to Akebia Therapeutics. The stock price of Q32 Bio has increased by 61.7% year-to-date in 2026 and by 223.08% from May 5, 2025, to May 4, 2026.

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)
Q32 Bio, Inc. (QTTB) Live Stock Price, Chart & Financial News | Edge Hound